Active, not recruitingNot applicableNCT01946854
Crossover Trial of Systemic Chemotherapy in Patients With Metastatic Well-Differentiated Mucinous Appendiceal Adenocarcinomas With Pseudomyxoma Peritonei
Studying Mucinous adenocarcinoma of the appendix
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- M.D. Anderson Cancer Center
- Principal Investigator
- Keith F. Fournier, MDM.D. Anderson Cancer Center
- Intervention
- Questionnaire(behavioral)
- Enrollment
- 30 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2013 – 2026
Study locations (1)
- University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01946854 on ClinicalTrials.govOther trials for Mucinous adenocarcinoma of the appendix
Additional recruiting or active studies for the same condition.
See all trials for Mucinous adenocarcinoma of the appendix →